Impact Health Labs LLC
Impact Health Labs LLC was paid $33K by Medicaid between Sep 2020 and Nov 2024, across 32 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 62% of everything it billed.
GEORGETOWN, TX 78626
Next to other Clinical Medical Laboratory providers in Texas
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 2,822 | $18K | |
| 2021 | 5,550 | $12K | |
| 2022 | 4,224 | $937.61 | |
| 2023 | 4,883 | $2K | |
| 2024incomplete | 3,415 | $134.65 |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 62% | 2,451 | 731 | $21K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 20% | 2,426 | 732 | $6K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 7.1% | 1,095 | 330 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 1,513 | 1,311 | $544.09 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.4% | 63 | 58 | $452.51 |
| 80053 | Comprehensive metabolic panel | 1.4% | 1,506 | 1,301 | $449.57 |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 954 | 825 | $361.89 |
| 80061 | Lipid panel | <1% | 881 | 752 | $324.65 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,053 | 774 | $283.92 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 360 | 259 | $259.76 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 756 | 509 | $239.92 |
| 87641 | <1% | 86 | 82 | $144.46 |
20 more codes
| 87481 | <1% | 45 | $140.03 | |
| 87500 | <1% | 59 | $86.97 | |
| 85027 | <1% | 323 | $64.89 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 15 | $58.97 |
| 87640 | <1% | 60 | $57.49 | |
| 81001 | <1% | 503 | $44.31 | |
| 83880 | <1% | 13 | $32.98 | |
| 87653 | <1% | 44 | $28.01 | |
| 87563 | <1% | 16 | $28.01 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 46 | $28.01 |
| 82607 | <1% | 341 | $12.04 | |
| 84165 | <1% | 136 | $9.02 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 24 | $6.78 |
| 82977 | <1% | 192 | $6.05 | |
| 81000 | <1% | 27 | $3.38 | |
| 83540 | 0% | 25 | $0.00 | |
| 82565 | 0% | 39 | $0.00 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 0% | 3,077 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 2,748 | $0.00 |
| 82746 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.